METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS Russian patent published in 2010 - IPC A61H1/00 A61K31/155 A61K31/22 A61K31/41 A61P3/06 A61P3/10 A61P9/12 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to haematology, cardiology, endocrinology, and can be used for correction of the blood microvesicle level in the patients with arterial hypertension with dyslipidemia and type II diabetes mellitus. That is ensured by graduated physical exercises and the administration of Valsartan 80 mg once in the morning, Lovastatin 40 mg once a day in the evening at mealtimes and Metformin 500 mg twice a day. The length of treatment is at least 6 weeks.

EFFECT: method ensures reduced risk of thrombotic complications, higher clinical effectiveness and improved prognosis in the case patients due to the rating correction of the blood microvesicle level.

1 ex